well not the kick along we hoped for today!still alot of selling pressure everytime the sp jumps up a bit.oh well, maybe we'll be taken over tomorrow. for $3
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%